Both candidates are designed to move beyond single-pathway GLP-1 therapy, but they take very different routes: CagriSema combines an amylin analog with semaglutide, while Retatrutide compresses GIP, GLP-1, and glucagon agonism into one investigational peptide
Surprisingly, none of these parameters was further altered in semaglutide-treated LPD mice, suggesting that semaglutide does not enhance GH resistance nor further impairs IGF-1 production upon chronic protein malnutrition
Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue
The injectable medications have become so popular that their manufacturers have had trouble keeping up with demand
I lost about 40 pounds that I had gained from my medications
Our app gives patients the ability to do this while remaining HIPAA compliant